Company Analysis

Riot Platforms, Inc. (RIOT)

Nasdaq: RIOT · Finance Services · Castle Rock, CO · filing with the SEC since 2002
Grade4.8
◀ Past 4.5● Present 6.1▶ Future 3.5
1 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

11 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Riot Platforms, Inc.’s names, not what it holds today.

Patents granted
11
11 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
8
since 2001, to Dec 31, 2025
Names they are printed under
4
a former name
By yearGrantedApplications published
'05'07'08'09'10'13'14'18
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name4 counted
AspenBio Pharma, Inc. a former name
US, as the owner printed on each patent
8 granted
8 published
AspenBio, Inc. a former name
US, as the owner printed on each patent
1 granted
0 published
Bioptix LLC a former name
US, as the owner printed on each patent
1 granted
0 published
Venaxis, Inc. a former name
US, as the owner printed on each patent
1 granted
0 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Oct 23, 201810,105,417Methods and kits for maintaining pregnancy, treating follicular cysts, and synchronizing ovulation using luteinizing hormonePharmaceuticalsAspenBio Pharma, Inc.
Sep 16, 20148,835,386Activity of recombinant equine follicle stimulating hormonePharmaceuticalsVenaxis, Inc.
Sep 9, 20148,830,481Polarization based interferometric detectorMeasurementBioptix LLC
Aug 27, 20138,518,881Methods for inducing superovulation in ungulatesPharmaceuticalsAspenBio Pharma, Inc.
Nov 30, 20107,842,513Pregnancy detectionAnalysis of biological materialsAspenBio Pharma, Inc.
Mar 30, 20107,687,281Bovine pregnancy testMedical technologyAspenBio Pharma, Inc.
Mar 2, 20107,670,789Methods and devices for diagnosis of appendicitisAnalysis of biological materialsAspenBio Pharma, Inc.
Feb 9, 20107,659,087Methods and devices for diagnosis of appendicitisAnalysis of biological materialsAspenBio Pharma, Inc.
Mar 10, 20097,501,256Methods and devices for diagnosis of appendicitisAnalysis of biological materialsAspenBio Pharma, Inc.
Jul 1, 20087,393,696Bovine pregnancy testMedical technologyAspenBio Pharma, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
May 16, 20132013/0122528COMPOSITIONS AND METHODS FOR ASSESSING APPENDICITISComputer technologyAspenBio Pharma, Inc.
Jul 22, 20102010/0184070Methods and Devices for Diagnosis of AppendicitisAnalysis of biological materialsAspenBio Pharma, Inc.
Jun 3, 20102010/0136588Methods and Devices for Diagnosis of AppendicitisAnalysis of biological materialsAspenBio Pharma, Inc.
May 13, 20102010/0120677ACTIVITY OF RECOMBINANT EQUINE FOLLICLE STIMULATING HORMONEPharmaceuticalsAspenBio Pharma, Inc. · patent 8,835,386 granted from it
Jun 18, 20092009/0155813Methods and Devices for Diagnosis of AppendicitisAnalysis of biological materialsAspenBio Pharma, Inc. · patent 7,670,789 granted from it
Dec 18, 20082008/0312151COMPOSITIONS AND METHODS INCLUDING EXPRESSION AND BIOACTIVITY OF BOVINE FOLLICLE STIMULATING HORMONEPharmaceuticalsAspenBio Pharma, Inc. · patent 8,518,881 granted from it
Oct 25, 20072007/0249003METHODS AND DEVICES FOR DIAGNOSIS OF APPENDICITISAnalysis of biological materialsAspenBio Pharma, Inc. · patent 7,659,087 granted from it
Aug 9, 20072007/0184558Bovine Pregnancy TestMedical technologyAspenBio Pharma, Inc. · patent 7,687,281 granted from it

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton RIOT · research, not advice